The antioxidant, immune-regulatory, mitochondria-optimising and cancer apoptosis-inducing effects of melatonin, coupled to NAS trophic effects, make AhR regulation of the melatonergic pathway an important aspect of tumours and the tumour microenvironment [8] as well as chemoresistance [20]. This evidence concerns the gene AHR and neoplasm.